Maryam Sorkhou, Rachel H. Bedder & Tony P. George. (2021) The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review. Frontiers in Psychiatry 12.
Crossref
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Orlando Scoppetta Díaz Granados, Guillermo Alonso Castaño Pérez, Elisardo Becoña Iglesias & Sandra Milena Restrepo Escobar. (2020) Exploración psicométrica sobre deficiencia motivacional en consumidores de marihuana. Interdisciplinaria. Revista de Psicología y Ciencias Afines 37:1.
Crossref
Godwin Anywar, Esezah Kakudidi, Robert Byamukama, Jackson Mukonzo, Andreas Schubert & Hannington Oryem-Origa. (2020) Medicinal plants used by traditional medicine practitioners to boost the immune system in people living with HIV/AIDS in Uganda. European Journal of Integrative Medicine 35, pages 101011.
Crossref
David C. Rettew, Doris C. Gundersen, Erica Kirsten Rapp, Paula Riggs, Christine L. Miller, Monica C. Jackson, Kevin Sabet, Ben Cort & LaTisha L. Bader. 2020. Cannabis in Medicine. Cannabis in Medicine
65
132
.
Mark Evans, Rowan P. Ogeil & James G. Phillips. (2019) Cannabis, Decision‐Making, and Online Assistance Seeking. The American Journal on Addictions 28:6, pages 473-479.
Crossref
Sai Krishna Tikka & Deepak Cyril D’Souza. 2019. Cannabis Use Disorders. Cannabis Use Disorders
127
155
.
Casey J. RouletteBarry S. Hewlett. (2018) Patterns of Cannabis Use among Congo Basin Hunter-Gatherers. Journal of Ethnobiology 38:4, pages 517.
Crossref
Andrew Lac & Jeremy W. Luk. (2017) Testing the Amotivational Syndrome: Marijuana Use Longitudinally Predicts Lower Self-Efficacy Even After Controlling for Demographics, Personality, and Alcohol and Cigarette Use. Prevention Science 19:2, pages 117-126.
Crossref
R. Hirst, L. Sodos, S. Gade & L. Rathke. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
288
297
.
F. Arias-Horcajadas, N. Szerman, P. Vega, I. Basurte & B. Mesías. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
61
69
.
Shirley Y. Hill, Vinod Sharma & Bobby L. Jones. (2016) Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate. Psychiatry Research: Neuroimaging 255, pages 24-34.
Crossref
Rajiv Radhakrishnan, Peter H. Addy, R. Andrew Sewell, Patrick D. Skosnik, Mohini Ranganathan & Deepak Cyril D’Souza. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System
423
474
.
Adam R. Winstock & Monica J. Barratt. (2013) The 12‐month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Human Psychopharmacology: Clinical and Experimental 28:4, pages 390-393.
Crossref
R. Andrew Sewell, Patrick D. Skosnik, Icelini Garcia-Sosa, Mohini Ranganathan & Deepak Cyril D'Souza. (2010) Efeitos comportamentais, cognitivos e psicofisiológicos dos canabinoides: relevância para a psicose e a esquizofrenia. Revista Brasileira de Psiquiatria 32:suppl 1, pages 515-530.
Crossref
Deepak Cyril D’Souza, Richard Andrew Sewell & Mohini Ranganathan. (2009) Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry and Clinical Neuroscience 259:7, pages 413-431.
Crossref
Judith Saxton & Lisa Morrow. 2008. Dementias. Dementias
851
862
.
George A. Ricaurte, J. William Langston & Una D. McCANN. 2008. Neurology and General Medicine. Neurology and General Medicine
735
747
.
Merle G. Paule. 2008. Primate Models of Children's Health and Developmental Disabilities. Primate Models of Children's Health and Developmental Disabilities
301
323
.
Wayne HALL, LOUISA DEGENHARDT & GEORGE PATTON. 2008. Adolescent Addiction. Adolescent Addiction
117
148
.
Sara Smucker Barnwell, Mitch Earleywine & Rand Wilcox. (2006) Cannabis, motivation, and life satisfaction in an internet sample. Substance Abuse Treatment, Prevention, and Policy 1:1.
Crossref
A. Robert Segarra, A. Torres Giménez, A. Tejero Pociello, C. Campo López & J. Pérez de los Cobos. (2006) Efectos esperados y adversos del consumo de cannabis en sujetos dependientes de los tetrahidrocannabinoides. Trastornos Adictivos 8:3, pages 148-154.
Crossref
Michael T. Lynskey, Carolyn Coffey, Louisa Degenhardt, John B. Carlin & George Patton. (2003) A longitudinal study of the effects of adolescent cannabis use on high school completion. Addiction 98:5, pages 685-692.
Crossref
H Ujike, M Takaki, K Nakata, Y Tanaka, T Takeda, M Kodama, Y Fujiwara, A Sakai & S Kuroda. (2002) CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Molecular Psychiatry 7:5, pages 515-518.
Crossref
Don R. Cherek, Scott D. Lane & Donald M. Dougherty. (2002) Possible amotivational effects following marijuana smoking under laboratory conditions.. Experimental and Clinical Psychopharmacology 10:1, pages 26-38.
Crossref
Franjo Grotenhermen. 2002. Cannabis, Straßenverkehr und Arbeitswelt. Cannabis, Straßenverkehr und Arbeitswelt
153
211
.
Franjo Grotenhermen. 2002. Cannabis, Straßenverkehr und Arbeitswelt. Cannabis, Straßenverkehr und Arbeitswelt
251
294
.
Merle G Paule, John J Chelonis, Elizabeth A Buffalo, Donna J Blake & Patrick H Casey. (1999) Operant Test Battery Performance in Children. Neurotoxicology and Teratology 21:3, pages 223-230.
Crossref
Harriet de Wit, Jeffrey M. Kirk & Angela Justice. 1998. Handbook of Substance Abuse. Handbook of Substance Abuse
131
146
.
Bruce Phariss, Robert B. Millman & Ann Bordwine Beeder. 1998. Handbook of Substance Abuse. Handbook of Substance Abuse
147
158
.
Una D. McCann, Kelly A. Lowe & George A. Ricaurte. (2016) REVIEW ■ : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System. The Neuroscientist 3:6, pages 399-411.
Crossref
Peter L. Nelson. (2016) Cannabis Amotivational Syndrome and Personality Trait Absorption: A Review and Reconceptualization. Imagination, Cognition and Personality 14:1, pages 43-58.
Crossref
Huw Thomas. (2018) Psychiatric Symptoms in Cannabis Users. British Journal of Psychiatry 163:2, pages 141-149.
Crossref
Janis L. Cutler & Samuel G. Siris. (1991) “Panic-like” symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: Observations and implications. Comprehensive Psychiatry 32:6, pages 465-473.
Crossref
Richard W. Foltin, Marian W. Fischman, Joseph V. Brady, Daniel J. Bernstein, Richard M. Capriotti, Margaret J. Nellis & Thomas H. Kelly. (1990) MOTIVATIONAL EFFECTS OF SMOKED MARIJUANA: BEHAVIORAL CONTINGENCIES AND LOW-PROBABILITY ACTIVITIES. Journal of the Experimental Analysis of Behavior 53:1, pages 5-19.
Crossref
Thomas H. Kelly, Richard W. Foltin, Cleeve S. Emurian & Marian W. Fischman. (1990) Multidimensional behavioral effects of marijuana. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14:6, pages 885-902.
Crossref
David V. Sheehan & B. Ashok Raj. 1990. Handbook of Outpatient Treatment of Adults. Handbook of Outpatient Treatment of Adults
177
208
.
Richard W. Foltin, Marian W. Fischman, Joseph V. Brady, Thomas H. Kelly, Daniel J. Bernstein & Margaret J. Nellis. (2008) Marijuana and behavioral contingencies. Drug Development Research 20:1, pages 67-80.
Crossref
Richard W. Foltin, Marian W. Fischman, Joseph V. Brady, Thomas H. Kelly, Daniel J. Bernstein & Margaret J. Nellis. (1989) Motivational effects of smoked marijuana: Behavioral contingencies and high-probability recreational activities. Pharmacology Biochemistry and Behavior 34:4, pages 871-877.
Crossref
Mark S. GoldMark S. Gold. 1989. Marijuana. Marijuana
83
92
.
Ashok B Raj & David V Sheehan. (1988) Medical Evaluation of the Anxious Patient. Psychiatric Annals 18:3, pages 176-181.
Crossref
K. Tunving. (2007) Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica 72:3, pages 209-217.
Crossref
. (2010) Book Reviews. British Journal of Addiction 78:3, pages 327-327.
Crossref
M. K. Malik, A. Kumar & B. P. R. Bhatia. (1983) Cannabis ototoxicity. Indian Journal of Otolaryngology 35:3, pages 74-74.
Crossref
Armand M. NicholiJr.Jr.. (1983) The Nontherapeutic Use of Psychoactive Drugs. New England Journal of Medicine 308:16, pages 925-933.
Crossref
Christopher R. Creason & Morton Goldman. (2016) Varying Levels of Marijuana Use by Adolescents and the Amotivational Syndrome. Psychological Reports 48:2, pages 447-454.
Crossref
R.E. MEYER. 1978. Neuro-Psychopharmacology. Neuro-Psychopharmacology
1249
1261
.
L. S. Harris, W. L. Dewey & R. K. Razdan. 1977. Drug Addiction II. Drug Addiction II
371
429
.
Ellen L. Bassuk & Stephen C. SchoonoverSteven M. Mirin. 1977. The Practitioner’s Guide to Psychoactive Drugs. The Practitioner’s Guide to Psychoactive Drugs
235
311
.
S.C. Clark. (1975) Marihuana and the cardiovascular system. Pharmacology Biochemistry and Behavior 3:2, pages 299-306.
Crossref
Roger E. Meyer. 1975. Marijuana and Health Hazards. Marijuana and Health Hazards
133
152
.
. (1974) REFERENCES. Acta Psychiatrica Scandinavica 50, pages 56-62.
Crossref
Paula D. Gordon. (1995) Toward the Resolution of the Controversy Surrounding the Effects and Social Health Implications of Marijuana Use. Journal of Drug Education 4:1, pages 13-25.
Crossref
Jan Herha. (1974) Haschisch und Marihuana—Eine Übersicht. The Science of Nature 61:2, pages 70-74.
Crossref
JARED R. TINKLENBERG. 1974. Marijuana. Marijuana
339
357
.
JAMES A. HALIKAS. 1974. Marijuana. Marijuana
265
302
.
Brigitte WoggonBrigitte Woggon. 1974. Haschisch. Haschisch
117
150
.
George R. Thompson, Marcus M. Mason, Harris Rosenkrantz & Monique C. Braude. (1973) Chronic oral toxicity of cannabinoids in rats. Toxicology and Applied Pharmacology 25:3, pages 373-390.
Crossref
ERICH GOODE. 1973. Drugs and Youth: the Challenge of Today. Drugs and Youth: the Challenge of Today
33
72
.
Richard Colestock Pillard. (1970) Marihuana. New England Journal of Medicine 283:6, pages 294-303.
Crossref
A. Peter McGraw, Caleb Warren, Bram Van Den Bergh & Michaela Cuneo. (2015) Marijuana and Utility Maximization. SSRN Electronic Journal.
Crossref